The present invention relates to novel insertion sites useful for the integration of exogenous sequences into the Modified Vaccinia Ankara (MVA) virus genome. The present invention further provides plasmid vectors to insert exogenous DNA into the genome of MVA. Furthermore, the present invention provides recombinant MVA comprising an exogenous DNA sequence inserted into said new insertion site as medicine or vaccine.

 
Web www.patentalert.com

< Glycopeptide conjugates and uses thereof

> Targeting of Herpes simplex virus to specific receptors

> Attenuation of cytomegalovirus virulence

~ 00529